KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio
KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio
Share This Story
Category ID
46
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
Share This Story
yahoo! news: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
John Sarantopoulos, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, and medical oncologist, Mays Cancer Center, was mentioned in this article. Read More
Share This Story
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
Share This Story
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s
Share This Story